Moat Ross sold KNSA
September 4, 2025 · Form 4 insider transaction
Moat Ross sold 3,523 shares of Kiniksa Pharmaceuticals International, plc at $35.31 per share, a transaction worth $124.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,523
Price
$35.31
Total value
$124.4K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2025
Filing dateSeptember 8, 2025
Shares owned after9,415
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.